NAMI
GILD icon

Nomura Asset Management International’s Gilead Sciences GILD Stock Holding History

Nomura Asset Management International’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$476M Buy
3,768,793
+321,682
+9% +$42.4M 0.71% 17
2026
Q1 		$480M Sell
3,447,111
-112,521
-3% -$15.8M 0.82% 13
2025
Q4 		$437M Buy
+3,559,632
New +$433M 0.66% 16

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nomura Asset Management International's GILD Position: Q2 2026 in Review

Nomura Asset Management International increased its Gilead Sciences (GILD) stake by 9.3% in Q2 2026, buying an estimated $42.4M and bringing the position to 3,768,793 shares worth $476M. The position accounts for 0.71% of the portfolio, ranked #17.

Nomura Asset Management International first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $480M in Q1 2026. 2,265 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Nomura Asset Management International held 3,768,793 shares of Gilead Sciences worth $476M as of Q2 2026.
  • Nomura Asset Management International bought 321,682 Gilead Sciences shares in Q2 2026, an estimated $42.4M.
  • Gilead Sciences made up 0.71% of Nomura Asset Management International's portfolio in Q2 2026, its #17 holding.
  • Nomura Asset Management International first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Nomura Asset Management International's Gilead Sciences position peaked at $480M in Q1 2026.
  • 2,265 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.